PlainRecalls
FDA Drug Moderate Class II Ongoing

Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77.

Reported: December 19, 2018 Initiated: November 20, 2018 #D-0314-2019

Product Description

Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77.

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.

Details

Units Affected
12,840 bottles
Distribution
Product was distributed throughout the United States.
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77.. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 12,840 bottles.
Why was this product recalled?
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 19, 2018. Severity: Moderate. Recall number: D-0314-2019.